Summary
Brain sections from cases of human Creutzfeldt-Jakob disease, Gerstmann-Sträussler syndrome, kuru, and hamster scrapie containing amyloid were examined for the presence of sulfated glycosaminoglycans (GAGs), the anionic component of proteoglycans, using the sulfated Alcian blue method and Alcian blue technique with 0.3 M and 0.7 M magnesium chloride. These studies suggest that sulfated glycosaminoglycans are part of the CNS amyloid plaques in each of the above human prion disorders as well as in experimental scrapie. All the amyloid plaques stained positively with Alcian blue at 0.3 M, and less so at 0.7 M magnesium chloride indicating the presence of sulfated GAGs. Therefore, the amyloid plaques of prion diseases possess similar histochemical features to those found in Alzheimer's disease.
Similar content being viewed by others
References
Beck E, Daniel PM, Parry HB (1964) Degeneration of the cerebellar and hypothalamo-neurohypophysial systems in sheep with scrapie, and its relationship to human system degenerations. Brain 87:153–176
Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB (1984) Antibodies to a scrapie prion protein. Nature 310:418–421
Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311
Bolton DC, Meyer RK, Prusiner SB (1985) Scrapie PrP 27-30 is a sialoglycoprotein. J Virol 53:596–606
Bruce M, Fraser M (1975) Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropathol Appl Neurobiol 1:189–202
DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41:221–235
DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37:1271–1280
Dorling J (1969) Critical electrolyte concentration method in histochemistry. J Med Lab Technol 26:124–130
Edwards RA, Woody RW (1979) Spectroscopic studies of Cibacron blue and Congo red bound to dehydrogenases and kinases. Evaluation of dyes as probes of the dinucleotide fold. Biochemistry 18:5197–5204
Gerstmann J, Sträussler E, Scheinker I (1936) Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol 154:736–762
Ihara Y, Abraham C, Selkoe DJ (1983) Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature 304:727–730
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530–532
Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Methods in laboratory investigation; formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230–236
Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of kuru. Lab Invest 9:799–847
Lendrum AC, Sidders W, Fraser S (1972) Renal hyalin: a study of amyloidosis and diabetic fibrinous vasculosis with new staining methods. J Clin Pathol 25:373–396
Marsh RF, Kimberlin RH (1975) Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogenesis. J Infect Dis 131:104–110
Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain 104:535–558
Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) Creutzfeldt-Jakob disease virus isolations from the Gertmann-Sträussler syndrome: with analysis of various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104:559–588
Masters CL, Multhaup C, Simms C, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757–2763
McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57–62
McLean IW, Nakane PK (1974) Periodate-lysine-paraformaldehyde fixative. A new fixative for immuno-electron microscopy. J Histochem Cytochem 22:1077–1083
Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525–527
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
Prusiner SB (1987) Prions and neurodegenerative diseases. N Engl J Med 317:1571–1581
Prusiner SB, DeArmond SJ (1987) Biology of disease; prions causing nervous system denegeration. Lab Invest 56:349–363
Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM (1980) Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19:4883–4891
Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353–358
Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10:355–364
Scott JE, Dorling J (1965) Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 5:221–233
Snow AD, Kisilevsky R (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: a histochemical study. Lab Invest 53:37–44
Snow AD, Kisilevsky R, Stephens C, Anastassiades T (1987) Characterization of tissue and plasma glyosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest 56:665–675
Snow AD, Willmer J, Kisilevsky R (1987) Sulphated glycosaminoglycans: a common constituent of all amyloids? Lab Invest 56:120–123
Snow AD, Willmer JP, Kisilevsky R (1987) Sulphated glycosaminoglycans in Alzheimer's disease. Hum Pathol 18:506–510
Snow AD, Mar H, Nochlin D, Wight TN (1988) Ultrastructural immunolocalization of heparan sulfate proteoglycans to amyloid fibrils in the neuritic plaques of Alzheimer's disease. J Neuropathol Exp Neurol 47:355 [abstr]
Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229–240
Szumanska G, Vorbrodt AW, Wisniewski HM (1986) Lectin histochemistry of scrapie amyloid plaques. Acta Neuropathol (Berl) 69:205–212
Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve R (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528–530
Vorbrodt AW, Dobrogowska DH, Kim YS, Lossinsky AS, Wisniewski HM (1988) Ultrastructural studies of glycoconjugates in brain micro-blood vessels and amyloid plaques of scrapie-infected mice. Acta Neuropathol (Berl) 75:277–287
Willmer JP, Snow AD, Kisilevsky R (1986) The demonstration of sulfated glycosaminoglycans (GAGs) in association with the amyloidotic lesions of Alzheimer's disease. J Neuropathol Exp Neurol 45:340 [abstr]
Wisniewski HM, Bruce ME, Fraser H (1975) Infectious etiology of neuritic (senile) plaques in mice. Science 190:1108–1110
Wong CW, Quaranta V, Glenner GG (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 82: 8729–8732
Author information
Authors and Affiliations
Additional information
Supported by Grant MT-3153 from the Medical Research Council of Canada, as well as research grants from the John Douglas French Foundation for Alzheimer's disease and the National Institutes of Health (NS22786, AG02132 and NS14069) and gifts from the R.J. Reynolds Industries, Sherman Fairchild Foundation, and Joseph and Stephaine Koret Foundation
Rights and permissions
About this article
Cite this article
Snow, A.D., Kisilevsky, R., Willmer, J. et al. Sulfated glycosaminoglycans in amyloid plaques of prion diseases. Acta Neuropathol 77, 337–342 (1989). https://doi.org/10.1007/BF00687367
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00687367